THE GENOMEWEB INTERVIEW: In Spite of a Bubbling Maelstrom, Compugen Looks Ahead | GenomeWeb

NEW YORK, April 3 - According to Robertson Stephens, Compugen "is having its most successful year." Recent collaborations with Millennium Pharmaceuticals, Gene Logic, and DiaDexus have broadened the company's external R&D footprint, while in-house the firm has used its LEADs platform to discover a pair potentially lucrative proteins. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.